🇺🇸 FDA
Patent

US 10787472

Prodrugs of pyridone amides useful as modulators of sodium channels

granted A61KA61K31/675A61K45/06

Quick answer

US patent 10787472 (Prodrugs of pyridone amides useful as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/675, A61K45/06, A61P, A61P1/00